Zhi Tong Cai Jing·2025-08-29 09:25Core Viewpoint - The company, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., a subsidiary of Baiyunshan (600332)(00874), has received a production license from the Guangdong Provincial Drug Administration, allowing it to produce drugs and renovate its small-volume injection production line, which is expected to optimize capacity and meet market demand [1]. Group 1 - The company has been granted a "Drug Production License" for commissioned drug production limited to registered products [1]. - The renovation of the small-volume injection production line and the solid oral dosage form workshop for cephalosporin production has passed the compliance inspection for drug production quality management standards [1]. - The new license and production capabilities are expected to enhance the company's production capacity to better satisfy market needs [1]. Group 2 - The impact of this license on the company's current performance is not expected to be significant [1].